Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             354 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 AB derivatives as potentially safer vaccines for Alzheimer’s disease Asuni, Ayodeji
2005
1 1S p. S68-S69
2 p.
artikel
2 A biomarkers and Alzheimer’s disease knowledge discovery tool Fuller, Sherrilynne S.
2005
1 1S p. S15-S16
2 p.
artikel
3 Abnormalities of regional cerebral blood flow in subclassifications of mild cognitive impairment Yamashita, Fumio
2005
1 1S p. S37-S38
2 p.
artikel
4 AB42 peptides, tau, and P-tau181P as biomarkers for early diagnosis: A multiparametric approach using xMAP™ technology Vanderstichele, Hugo M.
2005
1 1S p. S10-
1 p.
artikel
5 A Brief Alzheimer’s screen for Use in clinical practice Schmitt, Frederick A.
2005
1 1S p. S89-
1 p.
artikel
6 Accelerated cleavage of Notch-1 and beta-amyloid precursor protein during prion disease Clever, Jared L.
2005
1 1S p. S64-
1 p.
artikel
7 Acceleration of regional brain loss during progression of Alzheimer’s disease Navarro, Roberto
2005
1 1S p. S53-
1 p.
artikel
8 A comparative study of mini-mental state exam and the Saint Louis University mental status for detecting mild cognitive impairment Heyn, Patricia C.
2005
1 1S p. S35-
1 p.
artikel
9 Acquisition of face-name associations in early Alzheimer’s disease: A comparison of different methods Bier, Nathalie
2005
1 1S p. S60-
1 p.
artikel
10 AD Vaccination using HSV amplicons Federoff, Howard
2005
1 1S p. S107-S108
2 p.
artikel
11 Advanced MRI Koretsky, Alan
2005
1 1S p. S8-
1 p.
artikel
12 Alcohol consumption and cognitive decline in a biracial population of older persons Aggarwal, Neelum T.
2005
1 1S p. S35-
1 p.
artikel
13 Alpha-PSP may prevent neurovulnerable in Alzheimer model in vitro Sawatsri, Sayan
2005
1 1S p. S71-
1 p.
artikel
14 Alpha secretase Buxbaum, Joseph
2005
1 1S p. S2-
1 p.
artikel
15 Alpha-secretase as a therapeutic target Fahrenholz, Falk
2005
1 1S p. S91-
1 p.
artikel
16 Alzheimer’s disease drug discovery targeted to the APP mRNA 5′ untranslated region, paroxetine proof-of-concept for a validated target Rogers, Jack T.
2005
1 1S p. S71-
1 p.
artikel
17 Alzheimer’s disease, genetic Knowledge among African Americans Hipps, Yvonne G.
2005
1 1S p. S59-
1 p.
artikel
18 Alzheimer’s disease: The importance of an educational and empowerment program in the South of Brazil Hartmann, Ana Cristina V.
2005
1 1S p. S56-S57
2 p.
artikel
19 Amyloid deposits imaging by passive staining in mouse models of Alzheimer’s disease Dhenain, Marc
2005
1 1S p. S39-
1 p.
artikel
20 Amyloid imaging in Alzheimer’s disease and dementia with lewy bodies with 11C-PIB-PET Villemagne, Victor L.
2005
1 1S p. S41-S42
2 p.
artikel
21 Amyloid imaging with Pittsburgh Compound B Mathis, Chester A.
2005
1 1S p. S6-S7
2 p.
artikel
22 Amyloid imaging with Pittsburgh Compound-B in late-life depression Meltzer, Carolyn C.
2005
1 1S p. S85-
1 p.
artikel
23 Amyloid immunotherapy, extra-CNS actions Holtzman, David
2005
1 1S p. S1-
1 p.
artikel
24 Amyloid load in mild cognitive impairment compared to Alzheimer patients and normal subjects: An 11C-PIB PET study Edison, Paul
2005
1 1S p. S44-
1 p.
artikel
25 A new polymorphism in the promoter region of the hydroxy-methyl-glutaryl coenzyme a reductase is a risk factor for Alzheimer’s disease and influences the rate of cognitive decline Porcellini, Elisa
2005
1 1S p. S27-S28
2 p.
artikel
26 An fMRI investigation of memory-related medial temporal lobe activation in mild cognitive impairment prior to dementia Dickerson, Bradford C.
2005
1 1S p. S38-
1 p.
artikel
27 Antagonists of metal-dependent oxidation and protein interactions Bush, Ashley I.
2005
1 1S p. S3-
1 p.
artikel
28 Antioxidants for the prevention of dementia: Overview of the preadvise trial Runyons, Cecil R.
2005
1 1S p. S74-
1 p.
artikel
29 Antioxidants in prevention of AD: Dissapointments and possibilities Blass, John P.
2005
1 1S p. S74-
1 p.
artikel
30 A phase model for family caregiving: Evidence from internet support groups Caron, Wayne A.
2005
1 1S p. S55-S56
2 p.
artikel
31 A pilot data analysis on the Columbia University lithium archives project Dacpano, Geraldine
2005
1 1S p. S66-
1 p.
artikel
32 A placebo-controlled, double-blind trial of the selective AB-42 lowering agent, flurizan (MPC-7869, (R)-flurbiprofen) in patients with mild to moderate Alzheimer’s disease Wilcock, Gordon K.
2005
1 1S p. S95-
1 p.
artikel
33 Apolipoprotein E, Alzheimer’s disease and cerebral amyloid angiopathy: Effects of apoE on amyloid-B metabolism suggest underlying mechanisms and potential treatments Holtzman, David M.
2005
1 1S p. S90-S91
2 p.
artikel
34 Apolipoprotein E and oral and written discourse: An examination of discourse fluency with older non-demented individuals at genetic risk for developing AD, and AD patients Rosen, Virginia M.
2005
1 1S p. S33-
1 p.
artikel
35 Apolipoprotein E isoform does not predict hipporcampal or entorhinal volume atrophy in nondemented older adults Woodruff-Pak, Diana S.
2005
1 1S p. S50-
1 p.
artikel
36 A review of dementia-specific screening tools utilized in African American populations Carter, Adah
2005
1 1S p. S17-S18
2 p.
artikel
37 Asian cross cultural issues in diagnosing dementia Chan, Agnes
2005
1 1S p. S106-S107
2 p.
artikel
38 Assessment of complex ADL is essential for the diagnosis of the MCI syndrome Perneczky, Robert
2005
1 1S p. S82-
1 p.
artikel
39 Associative and item memory as outcome measures for Alzheimer’s disease clinical trials: A pilot study Budson, Andrew E.
2005
1 1S p. S58-
1 p.
artikel
40 A systematic examination of exercise training outcomes on cognitively impaired and cognitively intact older adults Heyn, Patricia C.
2005
1 1S p. S63-
1 p.
artikel
41 Atherosclerosis and cognitive function in men without clinical symptoms of cardiovascular risk Muller, Majon
2005
1 1S p. S35-
1 p.
artikel
42 Attitudes, knowledge and intentions about genetic testing among relatives of Italian patients affected by familial dementia: Cross-cultural comparison with Americans Binetti, Giuliano
2005
1 1S p. S103-
1 p.
artikel
43 Author Index 2005
1 1S p. S114-S122
9 p.
artikel
44 A 5 year double blind, randomised trial on EGb 761® efficacy on the prevention of Alzheimer’s dementia in patients over 70 with memory complaint. Guidage study Vellas, Bruno
2005
1 1S p. S73-
1 p.
artikel
45 A 10-year follow-up of blood pressure and antihypertensive medication use in relationship to incident dementia from age 85 to 95 years Börjesson-Hanson, Anne
2005
1 1S p. S77-
1 p.
artikel
46 BACE Wong, Philip
2005
1 1S p. S3-
1 p.
artikel
47 Basic principles of amyloid PET imaging Mintun, Mark A.
2005
1 1S p. S4-
1 p.
artikel
48 Basic principles of FDG PET Jagust, William
2005
1 1S p. S4-
1 p.
artikel
49 Basic principles of fMRI Duyn, Jozef (Jeff) H.
2005
1 1S p. S4-
1 p.
artikel
50 Basic principles of MRI Koretsky, Alan
2005
1 1S p. S3-
1 p.
artikel
51 Basic principles of spectroscopy, and perfusion weighted imaging Schuff, Norbert W.
2005
1 1S p. S4-
1 p.
artikel
52 Beliefs about prevention and treatment of Alzheimer’s disease among African Americans Roberts, J. Scott
2005
1 1S p. S54-
1 p.
artikel
53 Benefit of herbal medicine use in donepezil-treated Alzheimer’s disease patients Maruyama, Masahiro
2005
1 1S p. S75-S76
2 p.
artikel
54 Best practice in training and implementing evidence-based care for behaviors Buettner, Linda L.
2005
1 1S p. S55-
1 p.
artikel
55 Beta-secretases for production of beta-amyloid in the major regulated secretory pathway are identified as cathepsins B and L: Implications for cysteine proteases as drug targets for AD Hook, Vivian Y.
2005
1 1S p. S74-S75
2 p.
artikel
56 Binding characteristics of novel MRI contrast agents for the detection of Alzheimer’s disease Goux, Warren J.
2005
1 1S p. S52-
1 p.
artikel
57 Binding of the amyloid-imaging PET tracer, Pittsburgh Compound-B, to post-mortem human brain tissue from the AN-1792 immunotherapy trial Klunk, William E.
2005
1 1S p. S50-S51
2 p.
artikel
58 Biomarkers 101 Growdon, John
2005
1 1S p. S8-
1 p.
artikel
59 Blocking the apolipoprotein E/amyloid-B interaction reduces amyloid-B load in AD transgenic mice Sadowski, Marcin
2005
1 1S p. S66-S67
2 p.
artikel
60 Brain and behavior in the Framingham Heart Study DeCarli, Charles
2005
1 1S p. S92-
1 p.
artikel
61 Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases Bartzokis, George
2005
1 1S p. S26-
1 p.
artikel
62 CANTAB in clinical practice - A turning point in early detection’ Secker, David
2005
1 1S p. S104-
1 p.
artikel
63 Caspase cleavage of GFAP within degenerating astrocytes may lead to a compromised blood-brain-barrier in the Alzheimer’s disease brain Rohn, Troy T.
2005
1 1S p. S66-
1 p.
artikel
64 Cerebrospinal fluid markers and change in MMSE score over an 8-year follow-up period - the population study of women in Gothenburg, Sweden Gustafson, Deborah
2005
1 1S p. S86-
1 p.
artikel
65 Changes in cognition in Huntington’s disease and its relationship to future cognition Duff, Kevin
2005
1 1S p. S17-
1 p.
artikel
66 Chronic distress in old age, age-related neuropathology, and dendritic atrophy in the CA3 subfield of the hippocampus Wilson, Robert S.
2005
1 1S p. S92-
1 p.
artikel
67 Chronic γ secretase inhibition can reduce amyloid load without evidence of Notch related pathology in the Tg2576 mouse Smith, David W.
2005
1 1S p. S75-
1 p.
artikel
68 Chronological events of neurological diseases Joshi, Harendra I.
2005
1 1S p. S22-
1 p.
artikel
69 Clinical features of mild cognitive impairment: Evaluation of ethnic influences Adair, John C.
2005
1 1S p. S54-
1 p.
artikel
70 Clinical progestins and their efficacy to promote neuron survival and neurogenesis Deng, Jinxia
2005
1 1S p. S69-
1 p.
artikel
71 Clinical proteomics to diagnose Alzheimer’s disease German, Dwight C.
2005
1 1S p. S14-
1 p.
artikel
72 Clinical trials of anti-amyloid agents Aisen, Paul S.
2005
1 1S p. S3-
1 p.
artikel
73 Coenzyme Q10 inhibited the opening of the mitochondrial permeability transition pore to protect SHSY5Y neuronal cells Li, Geng
2005
1 1S p. S72-S73
2 p.
artikel
74 Cognitive ERPs as biomarkers and predictors of dementia in mild cognitive impairment (MCI) Olichney, John M.
2005
1 1S p. S9-
1 p.
artikel
75 Cognitive impairment and cholinergic vulnerability in the rat model for multiple sclerosis D’Intino, Giulia
2005
1 1S p. S29-
1 p.
artikel
76 Cognitive rehabilitation intervention for persons with early stage AD: The BEST pilot study Lombardo, Nancy B. Emerson
2005
1 1S p. S61-S62
2 p.
artikel
77 Commonly available modifiers of amyloid metabolism: Curry, fatty acids and NSAIDs Cole, Greg M.
2005
1 1S p. S3-
1 p.
artikel
78 Common pattern of deficit in multinational MCI cohort identified by objective computerized cognitive assessment Goldstein, Felicia C.
2005
1 1S p. S18-
1 p.
artikel
79 Community of caring: A continuum of normalized evidence-based programs to maintain function Buettner, Linda L.
2005
1 1S p. S101-
1 p.
artikel
80 Comparison of ERP spectral bands for early diagnosis of Alzheimer Disease using multiresolution wavelet analysis Topalis, Apostolos
2005
1 1S p. S23-
1 p.
artikel
81 Compliance with neuropsychological testing may lead to underestimation of decline in Cognitively-Impaired-Not-Demented (CIND) individuals Jacova, Claudia
2005
1 1S p. S77-
1 p.
artikel
82 Computerised cognitive evaluation: 20 years of experience from the Cognitive Drug Research System Harrison, John
2005
1 1S p. S90-
1 p.
artikel
83 Computerized cognitive tests identify MCI in urban black individuals Doniger, Glen M.
2005
1 1S p. S24-
1 p.
artikel
84 Computer mouse motion analysis in computerized screening tests for dementia: Interaction design and analysis Korczyn, Amos D.
2005
1 1S p. S25-
1 p.
artikel
85 Consideration of grape seed extract as a preventive against Alzheimer disease Kim, Helen
2005
1 1S p. S100-S101
2 p.
artikel
86 Consumption of fruit and vegetable juices predicts a reduced risk of Alzheimer’s disease: The Kame Project Borenstein, Amy R.
2005
1 1S p. S60-S61
2 p.
artikel
87 Contents 2005
1 1S p. A1-A2
nvt p.
artikel
88 Correlations between cholesterol-related genetic risk scores and lower brain-imaging measurements of regional glucose metabolism Reiman, Eric M.
2005
1 1S p. S79-
1 p.
artikel
89 Correlations between the distribution of microglial activation and amyloid plaque load in Alzheimer’s disease: An 11C-PK11195 and 11C-PIB PET study Edison, Paul
2005
1 1S p. S84-S85
2 p.
artikel
90 Cortical Radioactive Brain Uptake (CRBU) - a new, practical method to screen for Alzheimer’s disease and other dementias Pretorius, Harold T.
2005
1 1S p. S49-S50
2 p.
artikel
91 Cortical thickness in Alzheimer’s disease Evans, Alan C.
2005
1 1S p. S7-
1 p.
artikel
92 CSF biomarkers Zetterberg, Henrik
2005
1 1S p. S8-
1 p.
artikel
93 Cultural effect of Alzheimer’s disease in the native American population Henderson, J. Neil
2005
1 1S p. S107-
1 p.
artikel
94 Cultural profiles of a memory clinic - Are we doing enough? Nadkarni, Shailesh K.
2005
1 1S p. S53-S54
2 p.
artikel
95 Cystatin C as biological marker in mild cognitive impairment predicting for VAD Ghidoni, Roberta
2005
1 1S p. S15-
1 p.
artikel
96 Dementia less likely to be diagnosed in older adults living alone Wilkins, Consuelo H.
2005
1 1S p. S81-
1 p.
artikel
97 Design and implementation of a multicenter trial of vitamin E in aging individuals with Down syndrome Walsh, Sally
2005
1 1S p. S94-
1 p.
artikel
98 Detection of very early preclinical dementia using longitudinal cognitive decline in healthy community dwelling volunteers Darby, David G.
2005
1 1S p. S105-
1 p.
artikel
99 Developing outcome measures for therapeutic trials for dementia in aging individuals with Down Syndrome Sano, Mary
2005
1 1S p. S81-S82
2 p.
artikel
100 Development of an environmental safety assessment tool for older persons: Field testing of the Cougar Home Safety Assessments versions 1 and 2 Fisher, Grace S.
2005
1 1S p. S63-S64
2 p.
artikel
101 Development of a new class of orally bioavailable and safe experimental therapeutics that attenuate disease progression in an Alzheimer’s disease-related mouse model Van Eldik, Linda J.
2005
1 1S p. S99-S100
2 p.
artikel
102 DHA and cognitive function in the elderly: A systematic review of the literature Noel, Kay
2005
1 1S p. S62-
1 p.
artikel
103 Diabetes mellitus and risk of Alzheimer’s disease in the Cache County study on memory, health, and aging Charoonruk, Gene
2005
1 1S p. S78-
1 p.
artikel
104 Diabetes mellitus and risk of developing Alzheimer’s dementia: Results from the Framingham study Akomolafe, Abimbola
2005
1 1S p. S26-S27
2 p.
artikel
105 Different degree of progression of Ammnestic Mild Cognitive Impairment in the community Luis, Fornazzari
2005
1 1S p. S24-
1 p.
artikel
106 Different effects of apolipoproteins E epsilon4 on cognitive declines in Alzheimer disease incident patients and normal elderly subjects Lee, Junyoung
2005
1 1S p. S33-
1 p.
artikel
107 Differential physical activity between MCI and normal elderly people-tone project Kato, Morimasa
2005
1 1S p. S63-
1 p.
artikel
108 Differential regulation of apolipoprotein E expression by estrogen receptor A and B isoform-selective ligands: Estrogen receptor selective hormone therapy Ming Wang, Jun
2005
1 1S p. S68-
1 p.
artikel
109 Differential sensitivity of cognitive complaints associated with amnestic MCI: Analysis of patient and informant reports Santulli, Robert B.
2005
1 1S p. S21-
1 p.
artikel
110 Differentiating between MCI and early dementia with a new, computerized neurocognitive screening battery Gualtieri, Thomas
2005
1 1S p. S105-
1 p.
artikel
111 Differentiation of early stage of Alzheimer’s disease and dementia with lewy bodies by FDG-PET Ishii, Kenji
2005
1 1S p. S49-
1 p.
artikel
112 Different patterns of hypoperfusion in frontotemporal dementia and Alzheimer’s disease by arterial spin labeling MRI Du, Antao
2005
1 1S p. S88-
1 p.
artikel
113 Diffusion tensor mri in preclinical AD: Diffusivity and anisotropy in MCI and older adults with cognitive complaints West, John D.
2005
1 1S p. S40-
1 p.
artikel
114 Direct measurement of adhesive forces in amyloid beta peptide structures Alcantar, Norma A.
2005
1 1S p. S11-
1 p.
artikel
115 Discovery, identification and validation of novel cerebrospinal fluid biomarkers of Alzheimer’s disease using SELDI-TOF mass spectrometry Davies, Huw A.
2005
1 1S p. S13-
1 p.
artikel
116 Discrepancies in cognitive history from patients and informants in relation to cognitive function Schofield, Peter W.
2005
1 1S p. S18-
1 p.
artikel
117 Distinguishing mild cognitive impairment, age associated memory impairment and healthy subjects using tests in the Cogtest library Sharma, Tonmoy
2005
1 1S p. S104-S105
2 p.
artikel
118 Does vitamin E use protect against dementia or increase the risk of mortality? Hayden, Kathleen M.
2005
1 1S p. S95-S96
2 p.
artikel
119 Donepezil and vitamin E in the progression of mild cognitive impairment to Alzheimer’s disease: A hazard-ratio analysis Thal, Leon J.
2005
1 1S p. S93-S94
2 p.
artikel
120 Do statins cause nicotinic receptor dysfunction? Davis, Bonnie M.
2005
1 1S p. S67-
1 p.
artikel
121 Drug-ranging study of intravenous immunoglobulin in patients with Alzheimer’s disease Weksler, Marc
2005
1 1S p. S94-S95
2 p.
artikel
122 Dysregulation of cell cycle regulating proteins in peripheral lymphocytes in the patients with Alzheimer’s disease Kim, Doh Kwan
2005
1 1S p. S16-
1 p.
artikel
123 Early cholinergic deficit in Alzheimer’s disease: Can cholinergic replacement therapy decrease deposition of B-amyloid? Potter, Pamela E.
2005
1 1S p. S76-
1 p.
artikel
124 Early detection and monitoring with MRI Weiner, Michael
2005
1 1S p. S6-
1 p.
artikel
125 Early detection of cognitive decline with embedded assessment Morris, Margaret E.
2005
1 1S p. S107-
1 p.
artikel
126 Early detection of dementia in Huntington’s disease: The Predict-HD study Paulsen, Jane S.
2005
1 1S p. S26-
1 p.
artikel
127 Early markers of Alzheimer’s disease in patients with minimal to mild cognitive impairment Devanand, D.P.
2005
1 1S p. S12-
1 p.
artikel
128 Editorial board 2005
1 1S p. A3-
1 p.
artikel
129 EEG BIS-AD correlates with metrics of cognitive function in healthy subjects and in patients with Alzheimer’s disease Leuchter, Andrew F.
2005
1 1S p. S10-
1 p.
artikel
130 EEG Z-score pattern matching diagnosis of AD Musha, Toshimitsu
2005
1 1S p. S25-
1 p.
artikel
131 Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) Skoog, Ingmar
2005
1 1S p. S95-
1 p.
artikel
132 Effect of memantine on behavioral outcomes in Alzheimer’s disease Cummings, Jeffrey L.
2005
1 1S p. S70-
1 p.
artikel
133 Effects of spatial normalization on detection of perirhinal cortex activation in individual subjects using fMRI Ramsay, Thomas Z.
2005
1 1S p. S40-S41
2 p.
artikel
134 Effects of testosterone supplementation on cognitive functioning in aging men: A systematic review Heyn, Patricia C.
2005
1 1S p. S59-
1 p.
artikel
135 Endogenous sex hormones and incidence of dementia in older men: The Honolulu-Asia Aging Study Geerlings, Mirjam I.
2005
1 1S p. S30-S31
2 p.
artikel
136 Enhanced memory function of elderly people by exercise intervention with enjoyable and mild intensity: Tone Project Soya, Hideaki
2005
1 1S p. S98-
1 p.
artikel
137 Environmental enrichment mitigates cognitive deficits in APP/PS1 transgenic mice Jankowsky, Joanna L.
2005
1 1S p. S99-
1 p.
artikel
138 Environmental enrichment prevents cognitive decline and induces memory-related gene expression in a mouse model of Alzheimer’s disease Potter, Huntington
2005
1 1S p. S99-
1 p.
artikel
139 Estrogen receptor beta selective ligands for prevention of neurodegeneration: From in silico screening to at bench bioanalysis Zhao, Liqin
2005
1 1S p. S67-
1 p.
artikel
140 Estrogen regulation of mitochondrial function: Target for therapeutics to prevent Alzheimer’s disease Nilsen, Jon
2005
1 1S p. S71-S72
2 p.
artikel
141 Evaluating disease-modifying effects of Alzheimer’s disease treatments: The European regulatory perspective Sampaio, Cristina
2005
1 1S p. S105-S106
2 p.
artikel
142 Facials emotions and positive diagnosis of Alzheimer’s disease with (M.A.R.I.E.) Method of Analysis and Research of the Emotion Integration Philippe, Granato
2005
1 1S p. S16-
1 p.
artikel
143 Findings from a mild memory loss clinic Marriott, Anna
2005
1 1S p. S19-
1 p.
artikel
144 Flow cytometric differentiation of oligomeric and fibrillar AB assembly states as biomarkers for Alzheimer’s disease Schaupp, Michael
2005
1 1S p. S12-S13
2 p.
artikel
145 fMRI and MEG evidence of increased regional brain activations associated with the APOE-E4 allele in healthy subjects in their third decade Mapua Filbey, Francesca
2005
1 1S p. S44-
1 p.
artikel
146 fMRI features of AD: Distinguishing Alzheimer’s disease from normal aging and other dementias with fMRI Sperling, Reisa
2005
1 1S p. S5-
1 p.
artikel
147 fMRI of language and semantic memory in amnestic mild cognitive impairment vandenberghe, Rik
2005
1 1S p. S37-
1 p.
artikel
148 Frequency of MCI subtypes in a clinical setting. The DESCRIPA study Visser, Pieter Jelle
2005
1 1S p. S102-S103
2 p.
artikel
149 Frontal hypoperfusion correlates with episodic memory deficits in mild cognitive impairment Duarte, Audrey
2005
1 1S p. S48-S49
2 p.
artikel
150 Fruit and vegetable intake and cognitive function in the elderly: The cache county study on memory, health and aging Wengreen, Heidi J.
2005
1 1S p. S100-
1 p.
artikel
151 FTD/ALS - A rare case with cognitive impairment and variety of speech disorders Gustaw, Katarzyna A.
2005
1 1S p. S22-
1 p.
artikel
152 Functional GAG mimetics as an approach for the treatment of amyloid diseases Tremblay, Patrick
2005
1 1S p. S2-
1 p.
artikel
153 Gait dynamics of persons with Alzheimer’s disease: An exploratory study Pope, Carol J.
2005
1 1S p. S57-
1 p.
artikel
154 Gender, APOE-e4 status, and hippocampal volume in mild cognitive impairment Fleisher, Adam
2005
1 1S p. S39-
1 p.
artikel
155 Gender differences in navigation strategy, not performance Cushman, Laura A.
2005
1 1S p. S22-S23
2 p.
artikel
156 Genes or stress? Ethnic perceptions about the causes of Alzheimers Disease Ferguson, Allison
2005
1 1S p. S54-
1 p.
artikel
157 Gene therapy Mallet, Jacques J.-B.
2005
1 1S p. S108-
1 p.
artikel
158 Genetic basis of cerebral amyloidosis Tanzi, Rudolph
2005
1 1S p. S1-
1 p.
artikel
159 Gray matter density correlates of judgment deficits in older adults with AD, MCI, and cognitive complaints: Validation of the Dartmouth Rabin Judgment Questionnaire (DRJQ) Rabin, Laura A.
2005
1 1S p. S20-S21
2 p.
artikel
160 Gray matter reduction in cognitively intact adults with the APOE E4 allele Wishart, Heather A.
2005
1 1S p. S43-
1 p.
artikel
161 Higher plasma IGF-I levels are associated with better cognitive performance in older women without diabetes Okereke, Olivia I.
2005
1 1S p. S10-
1 p.
artikel
162 High resolution hydration analysis as a tool for the early diagnosis of misfolding disorders Gau, Daniel
2005
1 1S p. S29-S30
2 p.
artikel
163 Hippocampal disconnection due to white matter loss in individuals with amnestic mild cognitive impairment Stoub, Travis R.
2005
1 1S p. S40-
1 p.
artikel
164 Hippocampal metabolic reductions in mild cognitive impairment and Alzheimer’s disease: Automated FDG-PET image analysis Mosconi, Lisa
2005
1 1S p. S50-
1 p.
artikel
165 Hippocampal shape abnormalities in early AD: A replication study Wang, Lei
2005
1 1S p. S52-S53
2 p.
artikel
166 Hippocampal subsegmentation versus traditional total volumetric measurements in detecting early changes in Alzheimer’s disease Oyoyo, Udo
2005
1 1S p. S35-S36
2 p.
artikel
167 Histological characterization of PIB binding to amyloid plaques in Alzheimer’s disease Ikonomovic, Milos D.
2005
1 1S p. S38-S39
2 p.
artikel
168 How good are single and multiple domains for characterizing MCI patients at risk for AD? De Santi, Susan
2005
1 1S p. S81-
1 p.
artikel
169 How to sort “mild” from “none” in 10 items or less: Geriatric screening for cognitive impairment Frank, Lori
2005
1 1S p. S90-
1 p.
artikel
170 How we use our brains: Reconceptionalizing protective and risk factors for dementia Brauner, Daniel J.
2005
1 1S p. S60-
1 p.
artikel
171 Human amyloid-imaging studies with Pittsburgh Compound-B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition? DeKosky, Steven T.
2005
1 1S p. S84-
1 p.
artikel
172 Hyperlipidemia as a risk factor for cognitive impairment: Evidence from fMRI studies in midlife women Maki, Pauline M.
2005
1 1S p. S77-S78
2 p.
artikel
173 Hyperphosphorylation of tau and inflammatory changes by TLR-3 mediated signal transduction in human SH-SY5Y neuroblastoma cells Begum, Nurun N.
2005
1 1S p. S72-
1 p.
artikel
174 Hypertension and small hippocampal volume predict prodromal phase of dementia in black but not in white: Is prevention targeting the right population? Rosano, Caterina
2005
1 1S p. S87-
1 p.
artikel
175 Identifying early changes in the pathogenesis of Alzheimer’s disease with potential diagnostic and therapetic relevance Stokin, Gorazd B.
2005
1 1S p. S32-
1 p.
artikel
176 Il-1A and M-CSF: Neurotoxic or neuroprotective markers in Alzheimer’s disease? Mitrasinovic, Olivera M.
2005
1 1S p. S13-S14
2 p.
artikel
177 IL-4 activated microglia support neurogenesis in the triple-transgenic model of Alzheimer’s disease Butovsky, Oleg
2005
1 1S p. S70-
1 p.
artikel
178 IL-6 allelic variation and medial temporal morphology in MCI and older adults with memory complaints Saykin, Andrew J.
2005
1 1S p. S82-S83
2 p.
artikel
179 Image processing Hill, Derek
2005
1 1S p. S4-
1 p.
artikel
180 Imaging Alzheimer’s disease and other dementias with PET Foster, Norman L.
2005
1 1S p. S5-
1 p.
artikel
181 Imaging Alzheimer’s disease pathology using T1 rho MRI Moonis, Gul
2005
1 1S p. S86-
1 p.
artikel
182 Imaging neuroinflammation in Alzheimer disease with [1–11C] arachidonic acid and positron emission tomography Rapoport, Stanley I.
2005
1 1S p. S41-
1 p.
artikel
183 Imaging the hippocampal formation in the early diagnosis of Alzheimer’s disease de Leon, Mony J.
2005
1 1S p. S4-S5
2 p.
artikel
184 Immunotherapy, intra and intra-CNS actions Heppner, Frank L.
2005
1 1S p. S1-S2
2 p.
artikel
185 Impact of time-scale choice on rate of cognitive decline: A case study from the national Alzheimer’s coordinating center minimum data set Kurland, Brenda F.
2005
1 1S p. S33-S34
2 p.
artikel
186 Impaired reverse helix recall: A sign of mild cognitive impairment Östberg, Per
2005
1 1S p. S19-
1 p.
artikel
187 Implementation of universal cognitive screening in primary care: Initial results Borson, Soo
2005
1 1S p. S89-
1 p.
artikel
188 Improved imaged-derived input function for study of human brain FDG-PET Guo, Hongbin
2005
1 1S p. S45-S46
2 p.
artikel
189 Improved screening approach for MCI and dementia in the elderly Simon, Ely
2005
1 1S p. S105-
1 p.
artikel
190 Influence of age, grey matter, and memory performance on fMRI activation in older adults Braskie, Meredith N.
2005
1 1S p. S49-
1 p.
artikel
191 In vitro model system to predict efficacy of estrogens to prevent versus treat Alzheimer’s disease Brinton, Roberta Diaz
2005
1 1S p. S75-
1 p.
artikel
192 In vivo detection of amyloid plaques in AD transgenic mice using gadolinium labeled ligands by MRI Sigurdsson, Einar
2005
1 1S p. S84-
1 p.
artikel
193 In vivo detection of gray matter loss in the degenerative dementias: Different profiles of Alzheimer’s, lewy body, frontotemporal dementias, and progressive aphasia Frisoni, Giovanni B.
2005
1 1S p. S46-
1 p.
artikel
194 In vivo [F-18]FDDNP microPET imaging of brain B-amyloid in a transgenic rat model of Alzheimer’s disease Kepe, Vladimir
2005
1 1S p. S45-
1 p.
artikel
195 Is apoE plasma level associated with MCI? Findings from the Framingham Heart Study Tocco, Michael
2005
1 1S p. S79-
1 p.
artikel
196 Is robot therapy effective against AD? Musha, Toshimitsu
2005
1 1S p. S58-S59
2 p.
artikel
197 Is there a cognitive deficit in early Alzheimer’s Chance, Britton
2005
1 1S p. S51-
1 p.
artikel
198 Keyword Index 2005
1 1S p. S109-S113
5 p.
artikel
199 Left hippocampal volume adds significant diagnostic accuracy to MMSE in the identification of MCI Sandstrom, Claire
2005
1 1S p. S20-
1 p.
artikel
200 Life-course psychosocial factors in relation to dementia in late life Fratiglioni, Laura
2005
1 1S p. S93-
1 p.
artikel
201 Lifestyle and other risk factors: Cognitive reserve Stern, Yaakov
2005
1 1S p. S93-
1 p.
artikel
202 Living alone with dementia: Early identification Harden, Tamara C.
2005
1 1S p. S103-
1 p.
artikel
203 Longitudinal structural models of growth and survival applied to the early detection of Alzheimer’s disease McArdle, John J.
2005
1 1S p. S29-
1 p.
artikel
204 Longitudinal study of moderate alcohol consumption and risk of dementia in an elderly community based sample Derby, Carol A.
2005
1 1S p. S31-S32
2 p.
artikel
205 Loss of awareness in Alzheimer’s disease (AD): Considerations of lack of insight and legal liabilities in the United States Licata, Charles A.
2005
1 1S p. S56-
1 p.
artikel
206 Loss of initiation and planning predicts progression from CIND to Alzheimer’s disease Hsiung, Ging-Yuek R.
2005
1 1S p. S80-
1 p.
artikel
207 Low binding of the amyloid PET tracer, PIB, to transgenic PS1/APP mouse brain compared to human AD brain explained by Bmax Klunk, William E.
2005
1 1S p. S38-
1 p.
artikel
208 Low carbohydrate dietary intake prevents amyloid neuropathology in a mouse model of Alzheimer’s disease Wang, Jun
2005
1 1S p. S99-
1 p.
artikel
209 LXR and PPARG synthetic ligands upregulate ABCAL expression and decrease AB secretion Koldamova, Radosveta
2005
1 1S p. S96-
1 p.
artikel
210 Management of dementia through ayurvedic formulation brahmi rasayana BR-2T in mice Joshi, Hanumanthachar
2005
1 1S p. S64-
1 p.
artikel
211 Managing memory loss: How early detection impacts individuals being diagnosed Beard, Renee L.
2005
1 1S p. S20-
1 p.
artikel
212 MCI progressors and non-progressors: Neuropsychological profiles fail to guarantee the prognosis Chertkow, Howard M.
2005
1 1S p. S21-
1 p.
artikel
213 Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4tesla Mueller, Susanne G.
2005
1 1S p. S52-
1 p.
artikel
214 Medial temporal lobe atrophy and white matter changes are associated with mild cognitive deficits in non-disabled elderly van der Flier, Wiesje M.
2005
1 1S p. S41-
1 p.
artikel
215 Memory preservation diet (C) 2005 for reducing risk and slowing progression of Alzheimer’s disease Lombardo, Nancy B. Emerson
2005
1 1S p. S59-S60
2 p.
artikel
216 Memtrax computerized memory test, a one-minute dementia screen Ashford, J.W.
2005
1 1S p. S23-
1 p.
artikel
217 Meta-analysis of 6-month memantine clinical trials in Alzheimer’s disease Doody, Rachelle S.
2005
1 1S p. S67-
1 p.
artikel
218 Methods to improve the detection of mild cognitive impairment Shankle, William R.
2005
1 1S p. S103-
1 p.
artikel
219 Mid-life plasma folate and vitamin B12 levels and cognitive function in older women Kang, Jae Hee
2005
1 1S p. S28-
1 p.
artikel
220 Mild cognitive impairment after Tick borne encephalitis Gustaw, Katarzyna A.
2005
1 1S p. S29-
1 p.
artikel
221 Modeling clinical change from normal aging to MCI, dementia, and death Kryscio, Richard J.
2005
1 1S p. S34-
1 p.
artikel
222 Modifiers of cholesterol metabolism Kovacs, Dora M.
2005
1 1S p. S2-
1 p.
artikel
223 Modulated expressions in behavior and APP processing in transgenic mice overexpressing NSE-controlled APPsw Oh, Jaeho
2005
1 1S p. S16-
1 p.
artikel
224 Monitoring autonomic nervous system response after sensory-motor stimulation exercises by using Heart Rate Variability Bragin, Valentin
2005
1 1S p. S60-
1 p.
artikel
225 Morphometric MRI study of hippocampal shape in MCI using spherical harmonics Shen, Li
2005
1 1S p. S47-
1 p.
artikel
226 MRI: Appearance of different dementias and their longitudinal changes Fox, Nick
2005
1 1S p. S6-
1 p.
artikel
227 MRI-based methods for diagnosing and measuring progression of AD Hampel, Harald
2005
1 1S p. S7-
1 p.
artikel
228 MR spectroscopy demonstrates presymptomatic changes in familial Alzheimer’s disease Godbolt, Alison K.
2005
1 1S p. S51-S52
2 p.
artikel
229 NAP (AL-108): A novel drug candidate for the treatment of Alzheimer’s disease Gozes, Illana
2005
1 1S p. S67-S68
2 p.
artikel
230 Natural history of amyloid-beta peptides in the CNS and periphery Younkin, Steven
2005
1 1S p. S1-
1 p.
artikel
231 Natural killer (NK) cell activity as an early marker of Alzheimer’s disease: Results from a three year follow-up study Prolo, Paolo
2005
1 1S p. S13-
1 p.
artikel
232 Needs of distance caregiving of cognitively impaired elders living alone at home: Implications for technology-based interventions Benefield, Lazelle E.
2005
1 1S p. S56-
1 p.
artikel
233 Neurocognitive morbidity in patients with sickle cell disease: A risk for Alzheimer’s disease? Johnson, Stephanie R.
2005
1 1S p. S30-
1 p.
artikel
234 Neurological understanding of ayurvedic medicine and it’s application to dementia prevention Lonsdorf, Nancy
2005
1 1S p. S62-S63
2 p.
artikel
235 Neuropathological and memory changes in transitions between normal aging, MCI, and mild Alzheimer’s disease Schmitt, Frederick A.
2005
1 1S p. S18-S19
2 p.
artikel
236 Neuroprotective effects of hormone replacement therapy in healthy postmenopausal women: A VBM study Boccardi, Marina
2005
1 1S p. S36-S37
2 p.
artikel
237 Novel infectious biomarkers of cognitive impairment Aiello, Allison E.
2005
1 1S p. S86-
1 p.
artikel
238 Novel multiplexed CSF biomarkers for antemortem Alzheimer’s diagnosis Lee, Kelvin
2005
1 1S p. S10-S11
2 p.
artikel
239 Oligomers/Protofibrials/ADDLs Krafft, Grant
2005
1 1S p. S1-
1 p.
artikel
240 One year follow-up analyses of scoring algorithms for a Mild Cognitive Impairment screen: The CANS-MCI Study Tornatore, Jane B.
2005
1 1S p. S24-S25
2 p.
artikel
241 On the usability of computerized cognitive tests for dementia screening Vered, Aharonson
2005
1 1S p. S17-
1 p.
artikel
242 Operational criteria for patient recruitment in trials of mild cognitive impairment Petersen, Ronald C.
2005
1 1S p. S87-
1 p.
artikel
243 Parahippocampal white matter abnormalities in APOE E4 carriers without ventricular enlargement Nierenberg, Jay
2005
1 1S p. S36-
1 p.
artikel
244 Pathologic confirmation of AD diagnoses in longitudinal, epidemiologic studies Bennett, David A.
2005
1 1S p. S102-
1 p.
artikel
245 Patterns of gray and white matter atrophy in the frontal and temporal lobes in FTD, SD, and AD patients Chao, Linda L.
2005
1 1S p. S36-
1 p.
artikel
246 Perception and care of elders with dementia in the Hmong American community Gerdner, Linda A.
2005
1 1S p. S54-S55
2 p.
artikel
247 Perceptual thresholds may reflect treatment effects in MCI Mapstone, Mark
2005
1 1S p. S58-
1 p.
artikel
248 PET and MR imaging in dementia prediction and diagnosis Jagust, William
2005
1 1S p. S6-
1 p.
artikel
249 PKR is activated in Alzheimer’s disease and in experimental models Page, Guylene
2005
1 1S p. S65-
1 p.
artikel
250 Plasma AB levels as a premorbid biomarker for cognitive decline, mild cognitive impairment (MCI) and Alzheimer disease (AD) Graff-Radford, Neill R.
2005
1 1S p. S12-
1 p.
artikel
251 Plasma amyloid beta protein 42 in non-demented persons aged 75-years: Effects of concomitant medication and medial temporal lobe atrophy Blasko, Imrich
2005
1 1S p. S15-
1 p.
artikel
252 Plasma biomarkers in Alzheimer’s disease diagnostic Pratico, Domenico
2005
1 1S p. S8-S9
2 p.
artikel
253 P300 (latency) event-related potential: An accurate predictor of memory impairment : Hormonal correlates Braverman, Eric R.
2005
1 1S p. S15-
1 p.
artikel
254 PN401 decreases neurodegeneration in models of Alzheimer’s, Huntington’s and Parkinson’s disease, neuroinflammation, excitotoxicity and has antiepileptic activity Saydoff, Joel
2005
1 1S p. S68-
1 p.
artikel
255 Polymorphisms in paraoxonase genes PON1, PON2 and PON3 are associated with late onset Alzheimer disease Erlich, Porat M.
2005
1 1S p. S32-
1 p.
artikel
256 Potentially modifiable risk factors for dementia: Evidence from identical twins Gatz, Margaret
2005
1 1S p. S79-
1 p.
artikel
257 Practice effects and cognitive outcome in older adults with mild cognitive deficits Duff, Kevin
2005
1 1S p. S81-
1 p.
artikel
258 Preclinical basis for the efficacy of memantine in Alzheimer’s disease Banerjee, Pradeep K.
2005
1 1S p. S65-
1 p.
artikel
259 Preclinical detection and differential diagnosis of Alzheimer’s disease using a visuospatial paired associates learning test (CANTAB PAL): Implications for screening and clinical trial sample enrichment Blackwell, Andrew D.
2005
1 1S p. S80-S81
2 p.
artikel
260 Predicting MCI progression to AD via automated analysis of T1-weighted MR image intensity Duchesne, Simon
2005
1 1S p. S83-
1 p.
artikel
261 Prediction of progression to dementia in patients with mild cognitive impairment combining FDG-PET imaging with apolipoprotein E genotyping Grimmer, Timo
2005
1 1S p. S31-
1 p.
artikel
262 Predictive accuracy of the extended Predementia Alzheimer disease Scale (PAS) for Alzheimer-type dementia in subjects with MCI Visser, Pieter Jelle
2005
1 1S p. S12-
1 p.
artikel
263 Predictive validity of neuropsychiatric subgroups on functional impairment and quality of life in Alzheimer’s disease patients over a 3-year period Tun, Saw-Myo
2005
1 1S p. S27-
1 p.
artikel
264 Predictors of progression through the recruitment process, from questionnaire response to enrollment, in an Alzheimer’s disease (AD) primary prevention trial Roth, Mary-Tara
2005
1 1S p. S76-
1 p.
artikel
265 Presenilin/Gamma secretase as a therapeutic target Wolfe, Michael S.
2005
1 1S p. S2-
1 p.
artikel
266 Preservation of episodic and semantic musical memory in severe Alzheimer’s disease Fornazzari, Luis
2005
1 1S p. S62-
1 p.
artikel
267 Prevalence of pre-dementia in Tone town, Japan: An importance notice of the coexisting of pre-dementia and depression Asada, Takashi
2005
1 1S p. S102-
1 p.
artikel
268 Prevention of Binswanger’s dementia is possible by correction of the platelet hyper-aggregability Fujita, Shigekiyo
2005
1 1S p. S97-
1 p.
artikel
269 Previous vitamin E supplement intake and memory impairment: A women’s health initiative ancillary study Dunn, Julie E.
2005
1 1S p. S71-
1 p.
artikel
270 Prodromal cognitive signs of dementia in 85 year-olds - validity of four sources of information in a three year follow-up Sacuiu, Simona
2005
1 1S p. S19-
1 p.
artikel
271 10/66 Program Prince, Martin
2005
1 1S p. S106-
1 p.
artikel
272 Prosopagnosia in a patient with acute right PCA infarct and bilateral PCA occlusion Cho, Soo-Jin
2005
1 1S p. S45-
1 p.
artikel
273 Protective effect of alpha lipoic acid and trans resveratrol on spatial memory deficits caused by intracerebroventricular streptozotocin in rats Sharma, Monisha
2005
1 1S p. S69-
1 p.
artikel
274 Protective effect of Japanese green tea against cognitive impairment in the elderly, a two-years follow-up observation Hasegawa, Tohru
2005
1 1S p. S100-
1 p.
artikel
275 Proton magnetic resonance spectroscopy in Alzheimer’s mouse model Marjanska, Malgorzata
2005
1 1S p. S9-
1 p.
artikel
276 Quantifying T1-rho in Alzheimer’s disease Borthakur, Ari
2005
1 1S p. S42-S43
2 p.
artikel
277 Quantitative MRI R2 relaxometry in elderly participants reporting memory loss: A useful tool for the potential early diagnosis of AD? Foster, Jonathan K.
2005
1 1S p. S48-
1 p.
artikel
278 Radioiodinated hydroxy quinoline derivatives as probes for amyloid plaque imaging and enhanced brain delivery via nanoparticles in mice Kulkarni, Padmakar V.
2005
1 1S p. S83-S84
2 p.
artikel
279 Regional cerebral metabolism in PSAPP double-transgenic mice changes with age and genotype Valla, Jon
2005
1 1S p. S48-
1 p.
artikel
280 Regional decline of brain perfusion in healthy aging detected with arterial spin labeling at 4T Schuff, Norbert W.
2005
1 1S p. S83-
1 p.
artikel
281 Regulation of stem cells in the brain of Streptozotocin induced lesions in mouse Haque, Niloufar
2005
1 1S p. S65-
1 p.
artikel
282 Regulation of the amyloid precursor protein processing by the 5-HT4 receptor and small G proteins Lezoualc’h, Frank
2005
1 1S p. S91-S92
2 p.
artikel
283 Regulatory issues 2005
1 1S p. S9-
1 p.
artikel
284 Respiratory function in relation to white matter lesions and lacunar infarcts: A longitudinal population-based study in women Guo, Xinxin
2005
1 1S p. S78-
1 p.
artikel
285 Resting FDG-PET in neurologically normal individuals reporting dream enactment behavior: Preclinical dementia with lewy bodies? Caselli, Richard J.
2005
1 1S p. S47-S48
2 p.
artikel
286 Resting-state fMRI distinguishes Alzheimer’s disease from healthy aging and frontotemporal lobar degeneration Greicius, Michael D.
2005
1 1S p. S87-S88
2 p.
artikel
287 Risk factors for Alzheimer’s disease—The Rotterdam Study Breteler, Monique M.B.
2005
1 1S p. S93-
1 p.
artikel
288 Sacramento Area Latino Study on Aging (SALSA) study Haan, Mary N.
2005
1 1S p. S106-
1 p.
artikel
289 Safety and efficacy of donepezil in a 12-week, open-label trial in African Americans with mild to moderate Alzheimer’s disease Griffith, Patrick
2005
1 1S p. S73-
1 p.
artikel
290 Screening for pre-dementia Alzheimer’s disease Buschke, Herman
2005
1 1S p. S88-S89
2 p.
artikel
291 Searching for pro-inflammatory gene clusters to assess the Alzheimer’s disease (AD) risk profile for the prevention and early therapy of the disease Licastro, Federico
2005
1 1S p. S28-
1 p.
artikel
292 Serial MR neuroimaging: Comparison at 3T and 1.5T Sneller, B.
2005
1 1S p. S42-
1 p.
artikel
293 Short-term effect of statins and NSAIDs on CSF beta-amyloid1–42 in healthy controls Mirza, Nadeem M.
2005
1 1S p. S98-S99
2 p.
artikel
294 Slower speed-of-processing is associated with presence of the apolipoprotein E4 allele O’Hara, Ruth
2005
1 1S p. S104-
1 p.
artikel
295 Soluble Abeta oligomers (ADDLs) in Alzheimer’s disease memory loss, therapeutics, and diagnostics Klein, William
2005
1 1S p. S91-
1 p.
artikel
296 Spontaneous cerebral emboli and progression of dementia: A potential target for intervention? Purandare, Nitin B.
2005
1 1S p. S32-
1 p.
artikel
297 Src tyrosine kinase signaling regulates microglial protection of neurons from excitotoxicity Mitrasinovic, Olivera M.
2005
1 1S p. S73-S74
2 p.
artikel
298 Statin use does not reduce cognitive decline in the elderly. The Cache County study Hayden, Kathleen M.
2005
1 1S p. S97-
1 p.
artikel
299 Statistical issues for developing Alzheimer screening tests Ashford, J.W.
2005
1 1S p. S88-
1 p.
artikel
300 Statistical parametric mapping (SPM) in mild Alzheimer’s disease: A SPECT study with linearization correction for 99mTc hexamethyl-propylene amine oxime (HMPAO) Ansar, Ashik B.
2005
1 1S p. S46-
1 p.
artikel
301 Stress, meditation and memory: An emerging hypothesis Shah, Yogesh
2005
1 1S p. S63-
1 p.
artikel
302 Subgroups of Alzheimer disease based on cerebrospinal fluid levels of molecular markers Iqbal, Khalid
2005
1 1S p. S87-
1 p.
artikel
303 Subscriber information page 2005
1 1S p. A4-
1 p.
artikel
304 Successful AD and MCI differentiation from normal aging via automated analysis of MR image features Duchesne, Simon
2005
1 1S p. S43-
1 p.
artikel
305 Systolic and diastolic blood pressure at least 10 years prior to onset of dementia and risk of dementia or Alzheimer’s disease (AD) Roberts, Rosebud O.
2005
1 1S p. S34-
1 p.
artikel
306 Telemedicine followup of cognitively impaired Choctaw Indians Weiner, Myron F.
2005
1 1S p. S76-
1 p.
artikel
307 The Alzheimer’s disease Assessment Scale - Cognitive Subscale (Japanese version): The performance in community-dwelling people with mild cognitive impairment Kodama, Chiine
2005
1 1S p. S25-S26
2 p.
artikel
308 The applicability of current concepts of MCI to early Presenilin-1 related Alzheimer’s Disease Ringman, John M.
2005
1 1S p. S23-
1 p.
artikel
309 The application of amyloid-imaging to the diagnosis and treatment of Alzheimer’s disease Klunk, William E.
2005
1 1S p. S5-
1 p.
artikel
310 The AQT© as a useful short screening test for dementia. Evidence from two European cultures Warkentin, Siegbert
2005
1 1S p. S80-
1 p.
artikel
311 The CANS-MCI: Self-administered screening for mild cognitive impairment Hill, Emory
2005
1 1S p. S104-
1 p.
artikel
312 The changes of cerebral glucose metabolism according to the clinical severity of Alzheimer’s disease Choo, IL Han
2005
1 1S p. S45-
1 p.
artikel
313 The Development of NIC5-15, a natural anti-diabetic agent, in the treatment of Alzheimer’s disease Wang, Jun
2005
1 1S p. S62-
1 p.
artikel
314 The development of psoriasin as a novel therapeutic agent in Alzheimer’s disease Qin, Weiping
2005
1 1S p. S11-
1 p.
artikel
315 The economics and pharmacoeconomics of mild cognitive impairment Fillit, Howard
2005
1 1S p. S101-
1 p.
artikel
316 The effectiveness of GETO extract in the treatment of mild cognitive impairment in community elderly Tian, Jinzhou
2005
1 1S p. S65-
1 p.
artikel
317 The effect of different diagnostic criteria for dementia on the validity of the MMSE: Results from a population study in Gothenburg, Sweden Wancata, Johannes
2005
1 1S p. S20-
1 p.
artikel
318 The effect of snoezelen (Multi-Sensory Behavior Therapy- MSBT) to increase independence in activities of daily living and reduce agitation and apathy of patients with dementia on a short term geriatric psychiatric unit Staal, Jason
2005
1 1S p. S61-
1 p.
artikel
319 The effect of social engagement on incident dementia and hippocampal volume: The Honolulu-Asia aging study Saczynski, Jane S.
2005
1 1S p. S27-
1 p.
artikel
320 The effects of age and Alzheimer’s disease on hippocampal volumes, a MRI study van de Pol, Laura A.
2005
1 1S p. S51-
1 p.
artikel
321 The effects of gender on the relationship between body mass index and CSF AB42 and tau levels Carlsson, Cynthia M.
2005
1 1S p. S14-
1 p.
artikel
322 The future of P-300 brainwave technology for Alzheimer’s diagnosis and care management Farwell, Lawrence A.
2005
1 1S p. S17-
1 p.
artikel
323 The GPCOG: A new tool for primary care physicians to detect dementia Brodaty, Henry
2005
1 1S p. S19-
1 p.
artikel
324 The H1c haplotype of the MAPT locus is associated with autopsy confirmed late onset Alzheimer’s disease Myers, Amanda J.
2005
1 1S p. S34-S35
2 p.
artikel
325 The impact of ApoE alleles on age-related myelin breakdown Bartzokis, George
2005
1 1S p. S28-
1 p.
artikel
326 The neuroethics of technology-based lifestyle interventions Bush, Shane S.
2005
1 1S p. S56-
1 p.
artikel
327 The pharmacologic prevention of Alzheimer’s disease Standridge, John B.
2005
1 1S p. S64-
1 p.
artikel
328 The potential economic impact of future treatments for dementia Langa, Kenneth M.
2005
1 1S p. S107-
1 p.
artikel
329 The primary pathogenetic role of vascular contains vasoactive substances, hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease Aliev, Gjumrakch
2005
1 1S p. S31-
1 p.
artikel
330 The Q&E is more sensitive than the clock draw, mini-cog, and 6-item screener in the detection of mild Alzheimer s disease (AD) Dash, Paul
2005
1 1S p. S90-
1 p.
artikel
331 Therapeutic effects of Ginkgo biloba extract EGB 761 in animal models of Alzheimer’s disease Luo, Yuan
2005
1 1S p. S72-
1 p.
artikel
332 Therapeutic effects of intranasal insulin in patients with AD and amnestic MCI Craft, Suzanne
2005
1 1S p. S96-
1 p.
artikel
333 The relationship between amyloid load, microglial activation, and cognition in Alzheimer’s disease: PET findings Brooks, David
2005
1 1S p. S6-
1 p.
artikel
334 The reveal study: The impact of genetic risk assessment with APOE disclosure for Alzheimer’s disease Green, Robert C.
2005
1 1S p. S101-S102
2 p.
artikel
335 The role of executive control in dementia Bullock, Roger
2005
1 1S p. S24-
1 p.
artikel
336 The role of residential setting in determining the risk of cognitive impairment and dementia Feldman, Howard
2005
1 1S p. S76-S77
2 p.
artikel
337 The role of statins in delaying Alzheimer’s disease. Circulating cholesterol levels, ApoE genotype and initial dementia severity influence the level of benefit produced by atorvastatin in mild-to-moderate AD: Results of the ADCLT Sparks, D. Larry
2005
1 1S p. S92-
1 p.
artikel
338 The translational control of peripheral cells is correlated with the decline of cognitive tests in Alzheimer’s disease Paccalin, Marc
2005
1 1S p. S11-
1 p.
artikel
339 The worldwide costs of dementia Winblad, Bengt
2005
1 1S p. S101-
1 p.
artikel
340 Time course of cognitive deficits in preclinical Alzheimer’s disease Small, Brent J.
2005
1 1S p. S78-
1 p.
artikel
341 T-817MA, a newly developing anti-Alzheimer’s agent, protects neurons and recovers memory impairment in amyloid B-infused rats and P301L tau-mutated mice Nakagawa, Masaya
2005
1 1S p. S69-S70
2 p.
artikel
342 Towards prevention of Alzheimer’s disease and related disorders: Risk factor and treatment identification with evidence-based methods Shankle, William R.
2005
1 1S p. S61-
1 p.
artikel
343 Transition from normal cognition to amnestic MCI to DAT: A ten-year longitudinal case study with annual comprehensive cognitive assessments Zec, Ronald F.
2005
1 1S p. S22-
1 p.
artikel
344 Use of angiotensin converting enzyme inhibitors and age of Alzheimer’s disease onset in patients with the Apolipoprotein E ϵ4 allele Hu, William T.
2005
1 1S p. S30-
1 p.
artikel
345 Use of lipid lowering agents and the risk of cognitive impairment not meeting dementia criteria in relation to apolipoprotein E status Rockwood, Kenneth
2005
1 1S p. S66-
1 p.
artikel
346 Use of NSAIDs and antioxidant supplements in combination reduces the rate of cognitive decline. The Cache County study Fotuhi, Majid
2005
1 1S p. S97-S98
2 p.
artikel
347 Using family history to enrich recruitment in prevention trials: Does relative’s age matter? Sano, Mary
2005
1 1S p. S98-
1 p.
artikel
348 Utility of a novel composite Neuropsychological Test Battery (NTB) for detecting cognitive change in early Alzheimer’s disease patients Harrison, John
2005
1 1S p. S58-
1 p.
artikel
349 Volume MRI study: The effects of Coenzyme Q10 in APP/PS1 mouse models of Alzheimer’s disease and cerebral ischemia Li, Geng
2005
1 1S p. S94-
1 p.
artikel
350 Volumetric measurement of the entorhinal cortex: A reliability analysis Wood, Mary F.
2005
1 1S p. S44-
1 p.
artikel
351 What causes and how can we prevent cognitive deficits in Alzheimer’s (AD)? Cole, Greg M.
2005
1 1S p. S96-S97
2 p.
artikel
352 What is the best dementia screening instrument for general practitioners to use? Brodaty, Henry
2005
1 1S p. S89-
1 p.
artikel
353 What’s in a label? An exploration of the psychosocial impact on an individual diagnosed with Mild Cognitive Impairment Lai, Claudia K.
2005
1 1S p. S55-
1 p.
artikel
354 Wisconsin registry for Alzheimer’s prevention: Prospective cohort study of preclinical AD Sager, Mark A.
2005
1 1S p. S32-S33
2 p.
artikel
                             354 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland